D.E. Shaw & Co’s Asensus Surgical, Inc. ASXC Stock Holding History

D.E. Shaw & Co’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,141	Closed	-$15K	–	6050
2021 Q4	$15K	Sell	13,141 -251,801	-95%	-$389K	﹤0.01%	5313
2021 Q3	$490K	Buy	264,942 +240,710	+993%	+$541K	﹤0.01%	4093
2021 Q2	$77K	Buy	+24,232	New	+$60.6K	﹤0.01%	4585
2019 Q4	–	Sell	-6,437	Closed	-$52K	–	4219
2019 Q3	$52K	Buy	+6,437	New	+$87.5K	﹤0.01%	3723
2019 Q2	–	Sell	-1,568	Closed	-$49K	–	3928
2019 Q1	$49K	Buy	+1,568	New	+$52.6K	﹤0.01%	3518
2018 Q4	–	Sell	-15,077	Closed	-$1.14M	–	4051
2018 Q3	$1.14M	Buy	+15,077	New	+$1.02M	﹤0.01%	2614
2018 Q2	–	Sell	-5,796	Closed	-$128K	–	3936
2018 Q1	$128K	Buy	5,796 +936	+19%	+$21.4K	﹤0.01%	3375
2017 Q4	$122K	Buy	+4,860	New	+$150K	﹤0.01%	3482

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co's ASXC Position: Q1 2022 in Review

D.E. Shaw & Co sold out of Asensus Surgical, Inc. (ASXC) in Q1 2022, closing a stake of 13,141 shares — an estimated $15K sold.

D.E. Shaw & Co first reported a position in ASXC in Q4 2017 and held it in 8 quarters. The position peaked at $1.14M in Q3 2018. 115 funds tracked by Wall St. Rank hold ASXC as of Q1 2022.

D.E. Shaw & Co reported no remaining Asensus Surgical, Inc. position as of Q1 2022 after selling out during the quarter.
D.E. Shaw & Co sold 13,141 Asensus Surgical, Inc. shares in Q1 2022, an estimated $15K.
D.E. Shaw & Co first reported a position in Asensus Surgical, Inc. in Q4 2017 and held it in 8 quarters.
D.E. Shaw & Co's Asensus Surgical, Inc. position peaked at $1.14M in Q3 2018.
115 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2022.

Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.